A study presented at TCT 2018 questioned the benefits of “drip-and-ship” for elderly patients with ST-segment elevation myocardial infarction (STEMI), finding patients in their 80s or older who were transferred with fibrinolytic therapy for PCI had an eight-fold risk of hemorrhagic stroke but no survival advantage.
Thumbnail
Fewer than one-third of Chinese patients with acute coronary syndromes (ACS) receive guidance to…
Thumbnail
Lorcaserin, an appetite suppressant approved for chronic weight management in 2012, reduced…
Thumbnail
With CMS set to release a new National Coverage Determination (NCD) for transcatheter aortic valve…
Thumbnail
Some cardiologists at TCT 2018 worried negative posts about ongoing trials could affect patient…
Thumbnail
A press conference at the 2018 Transcatheter Cardiovascular Therapeutics meeting in San Diego on…
Thumbnail
Acute coronary syndrome patients who were given a loading dose of atorvastatin before percutaneous…
Thumbnail
With additional testing for nonobstructive coronary artery disease (CAD), researchers effectively…
Thumbnail
Intravascular ultrasound (IVUS)-guided stent implantation offers improved clinical outcomes for…
Thumbnail
The Eluvia drug-eluting vascular stent system has been approved by the FDA, device maker Boston…
Thumbnail
A novel, polymer-free amphilius-eluting stent known as the “Cre8” was proven noninferior to the…
Thumbnail
SAN DIEGO — An endovascular ultrasound-based renal denervation (RDN) approach led to greater…
Thumbnail
OAC-ALONE, the first randomized trial to test the efficacy of oral anticoagulation (OAC) alone…